Derek Dustin

740 total citations
14 papers, 464 citations indexed

About

Derek Dustin is a scholar working on Cancer Research, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Derek Dustin has authored 14 papers receiving a total of 464 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Cancer Research, 6 papers in Molecular Biology and 5 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Derek Dustin's work include Cancer Genomics and Diagnostics (8 papers), Advanced Breast Cancer Therapies (3 papers) and Breast Cancer Treatment Studies (2 papers). Derek Dustin is often cited by papers focused on Cancer Genomics and Diagnostics (8 papers), Advanced Breast Cancer Therapies (3 papers) and Breast Cancer Treatment Studies (2 papers). Derek Dustin collaborates with scholars based in United States, Germany and Switzerland. Derek Dustin's co-authors include Suzanne A.W. Fuqua, Guowei Gu, Yassine Rechoum, Jin-Ah Kim, Funda Meric‐Bernstam, Filip Jankú, Mohamed A. Gouda, Sarina A. Piha‐Paul, Apostolia M. Tsimberidou and Aung Naing and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and Cancer Research.

In The Last Decade

Derek Dustin

14 papers receiving 459 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Derek Dustin United States	8	228	192	169	125	80	14	464
Yeung Ho United States	12	253 1.1×	123 0.6×	176 1.0×	248 2.0×	70 0.9×	13	537
Elisabeth Werner Rönnerman Sweden	11	200 0.9×	161 0.8×	160 0.9×	73 0.6×	31 0.4×	23	472
Wei Jing China	16	341 1.5×	269 1.4×	111 0.7×	199 1.6×	23 0.3×	45	694
Carla Azzurra Amoreo Italy	15	249 1.1×	193 1.0×	148 0.9×	75 0.6×	30 0.4×	25	492
Zeng-Quan Yang United States	12	488 2.1×	168 0.9×	151 0.9×	67 0.5×	46 0.6×	20	653
Aisling M. Redmond United Kingdom	14	405 1.8×	200 1.0×	196 1.2×	86 0.7×	223 2.8×	18	665
Yevgeniy Gindin United States	10	339 1.5×	89 0.5×	160 0.9×	44 0.4×	64 0.8×	18	511
Sophie Doisneau-Sixou France	12	283 1.2×	290 1.5×	177 1.0×	74 0.6×	186 2.3×	17	570
Christian Brueffer Sweden	10	267 1.2×	188 1.0×	231 1.4×	113 0.9×	90 1.1×	24	489

Countries citing papers authored by Derek Dustin

Since Specialization

Citations

This map shows the geographic impact of Derek Dustin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Derek Dustin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Derek Dustin more than expected).

Fields of papers citing papers by Derek Dustin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Derek Dustin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Derek Dustin. The network helps show where Derek Dustin may publish in the future.

Co-authorship network of co-authors of Derek Dustin

This figure shows the co-authorship network connecting the top 25 collaborators of Derek Dustin. A scholar is included among the top collaborators of Derek Dustin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Derek Dustin. Derek Dustin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

Janni, Wolfgang, Thomas W. P. Friedl, Lisa Wiesmüller, et al.. (2025). Detection of minimal residual disease and prediction of recurrence in breast cancer using a plasma-only circulating tumor DNA assay. ESMO Open. 10(4). 104296–104296. 9 indexed citations

Ademuyiwa, Foluso O., X. Cynthia, Katherine N. Weilbaecher, et al.. (2025). Detection of Circulating Tumor DNA Using a Tissue-Free Epigenomic Assay Is a Highly Prognostic Biomarker in Early-Stage Triple-Negative Breast Cancer. Clinical Cancer Research. 31(11). 2173–2182. 1 indexed citations

Llombart‐Cussac, Antonio, María Leonor Fernández-Murga, Eduardo Martínez de Dueñas, et al.. (2025). Circulating tumor DNA (ctDNA)-based minimal residual disease (MRD) measured by Guardant Reveal in patients (pts) with HER2-positive (HER2+) metastatic breast cancer (mBC) with long-term disease control on first-line trastuzumab-pertuzumab.. Journal of Clinical Oncology. 43(16_suppl). 1052–1052. 1 indexed citations

Quinn, Katie, Amy B. Wilfert, Sai Chen, et al.. (2025). Abstract 692: Analytical validation of a tissue-free epigenomic assay for circulating tumor DNA (ctDNA)-based molecular residual disease (MRD) detection in early-stage cancer. Cancer Research. 85(8_Supplement_1). 692–692. 1 indexed citations

Janni, Wolfgang, Thomas W. P. Friedl, Brigitte Rack, et al.. (2024). Abstract PS06-06: Analysis of ctDNA for the detection of minimal residual disease (MRD) using a tissue-free, multiomic assay in patients with early-stage breast cancer. Cancer Research. 84(9_Supplement). PS06–6. 4 indexed citations

Aaroe, Ashley, Razelle Kurzrock, Gaurav Goyal, et al.. (2023). Successful treatment of non-Langerhans cell histiocytosis with the MEK inhibitor trametinib: a multicenter analysis. Blood Advances. 7(15). 3984–3992. 21 indexed citations

Gouda, Mohamed A., Helen J. Huang, Sarina A. Piha‐Paul, et al.. (2022). Longitudinal Monitoring of Circulating Tumor DNA to Predict Treatment Outcomes in Advanced Cancers. JCO Precision Oncology. 6(6). e2100512–e2100512. 28 indexed citations

Gouda, Mohamed A., Jiří Polívka, Hong Huang, et al.. (2021). Ultrasensitive detection of BRAF mutations in circulating tumor DNA of non-metastatic melanoma. ESMO Open. 7(1). 100357–100357. 17 indexed citations

Dustin, Derek, Guowei Gu, Amanda Beyer, et al.. (2020). RON signalling promotes therapeutic resistance in ESR1 mutant breast cancer. British Journal of Cancer. 124(1). 191–206. 18 indexed citations

10.

Dustin, Derek, Guowei Gu, & Suzanne A.W. Fuqua. (2019). ESR1 mutations in breast cancer. Cancer. 125(21). 3714–3728. 185 indexed citations

11.

Dustin, Derek, et al.. (2018). The Impact of ESR1 Mutations on the Treatment of Metastatic Breast Cancer. Hormones and Cancer. 9(4). 215–228. 36 indexed citations

12.

Gu, Guowei, Lin Tian, Meng Gao, et al.. (2018). Abstract 22: The Y537S ESR1 mutation is a dominant driver of distant ER-positive breast cancer metastasis. Cancer Research. 78(13_Supplement). 22–22. 6 indexed citations

13.

Gu, Guowei, Derek Dustin, & Suzanne A.W. Fuqua. (2016). Targeted therapy for breast cancer and molecular mechanisms of resistance to treatment. Current Opinion in Pharmacology. 31. 97–103. 131 indexed citations

14.

Dustin, Derek, et al.. (2016). Neuroimaging in Alzheimer's disease: preclinical challenges toward clinical efficacy. Translational research. 175. 37–53. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact